Hepatitis, HIV/AIDS, human papillomavirus (HPV), meningococcal disease, typhoid, and yellow fever are among the various chronic diseases detected across the region. Similarly, in 2021, the Centers for Disease Control and Prevention (CDC) launched the global immunization strategic framework 2021–2030. The framework provides a plan to vaccinate against vaccine-preventable diseases (VPDs), such as hepatitis A and B. Moreover, there are different vaccine routines for travelers proposed by WHO to prevent the spread of deadly infectious diseases. The vaccine routine includes routine vaccines for review before traveling, vaccines for certain destinations, and vaccines demanded by certain countries. In most cases, booster doses of routine vaccines are required if people have not followed the regular schedule. Such initiatives by WHO and CDC enhance the vaccine demand, thereby driving its market growth. On the other hand, the COVID–19 outbreak threatened public health. Various emergency actions were initiated during the pandemic, of which the COVAX initiative was aggressively enacted. Vaccination against COVID–19 was mandatory for people worldwide. Governments in every region mandated vaccines for people traveling within and outside countries. The COVID-19 pandemic contributed significantly to travel vaccines. Thus, the factors mentioned above are driving the market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe travel vaccines market. The Europe travel vaccines market is expected to grow at a good CAGR during the forecast period.
Europe Travel Vaccines Market Segmentation
Europe travel vaccines market is segmented into product, application, and country. The Europe travel vaccines market, by product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. The Europe travel vaccines market, by application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the Europe travel vaccines market is segmented into France, Germany, Italy, the UK, Russia, and the Rest of Europe.
Abbott; Dynavax Technologies; Emergent BioSolutions Inc.; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Sanofi; and Valneva SE are among the leading companies in the travel vaccines market in the region.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 995.47 Million |
| Market Size by 2028 | US$ 1,885.56 Million |
| CAGR (2021 - 2028) | 9.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Travel Vaccines Market is valued at US$ 995.47 Million in 2021, it is projected to reach US$ 1,885.56 Million by 2028.
As per our report Europe Travel Vaccines Market, the market size is valued at US$ 995.47 Million in 2021, projecting it to reach US$ 1,885.56 Million by 2028. This translates to a CAGR of approximately 9.6% during the forecast period.
The Europe Travel Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Travel Vaccines Market report:
The Europe Travel Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Travel Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Travel Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Travel Vaccines Market
